Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

281
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
281
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

185
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
185
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

325
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
325
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

354
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
354
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and effectiveness of voxelotor in individuals with sickle cell disease in the RETRO and PROSPECT US registries.

Blood advances·2026
Same author

Metastatic Recurrence Among Adolescents and Young Adults With Cancer.

JAMA oncology·2025
Same author

Low bone mineral density and pain impact in adults with sickle cell disease.

Blood advances·2025
Same author

Association of IVCF use with mortality and intracranial hemorrhage in patients with selected cancers and brain metastasis.

Blood vessels, thrombosis & hemostasis·2025
Same author

Cancer Incidence and Trends in Persistent Poverty Areas of California by Race/Ethnicity and Sex.

Cancer medicine·2025
Same author

ASH sickle cell disease CPKD guidelines report.

Blood advances·2025

Related Experiment Video

Updated: Jan 9, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K

Sickle cell disease: managing thromboembolism.

Kavya Babu1, Ted Wun1

  • 1Division of Hematology and Oncology, Department of Internal Medicine, UC Davis Comprehensive Cancer Center, Sacramento, CA.

Hematology. American Society of Hematology. Education Program
|December 5, 2025
PubMed
Summary
This summary is machine-generated.

Sickle cell disease (SCD) increases blood clot risk due to coagulation changes. Thromboprophylaxis and anticoagulants like direct oral anti-Xa antagonists are key for managing venous thromboembolism (VTE) in these patients.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.2K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.3K

Related Experiment Videos

Last Updated: Jan 9, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.2K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.3K

Area of Science:

  • Hematology
  • Vascular Medicine
  • Pharmacology

Background:

  • Sickle cell disease (SCD) presents as an acquired hypercoagulable state.
  • SCD involves prothrombotic coagulation alterations, heightened platelet activation, and endothelial damage.
  • These pathological changes correlate with a higher incidence of venous thromboembolism (VTE).

Purpose of the Study:

  • To explore the role of primary thromboprophylaxis in sickle cell disease patients.
  • To investigate thromboprophylaxis strategies, particularly concerning central venous catheter use.
  • To examine prophylaxis during specific high-risk periods: perioperatively, late pregnancy, and postpartum.

Main Methods:

  • Review of existing literature on thromboprophylaxis in SCD.
  • Analysis of anticoagulant use patterns in SCD patients with VTE.
  • Comparison of treatment strategies with the general VTE population.

Main Results:

  • Direct oral anti-Xa antagonists are increasingly utilized for secondary prophylaxis in SCD patients with VTE.
  • Primary thromboprophylaxis is under consideration for specific high-risk scenarios in SCD.
  • The hypercoagulable state in SCD necessitates careful management of VTE risk.

Conclusions:

  • SCD patients exhibit a significant risk for VTE due to complex hematological and vascular changes.
  • Anticoagulant therapy, including direct oral anti-Xa antagonists, plays a crucial role in secondary VTE prevention.
  • Further research into primary thromboprophylaxis is warranted for specific high-risk SCD patient groups.